Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Glioma × Diffusion Magnetic Resonance Imaging × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 4 Glioblastoma 3 Esophageal Neoplasms 3 Recurrence 2 Esophageal Squamous Cell Carcinoma 2 Endometrial Neoplasms 2 Brain Neoplasms 2 Thyroid Neoplasms 1 Pathologic Complete Response 1 Oligodendroglioma 1 Lymphoma, Follicular 1 Lymphatic Metastasis 1 Li-Fraumeni Syndrome 1 Gliosarcoma 1 Glioma 1 Ependymoma 1 Disease 1 DWI-MRI 1 Chemotherapy Induced Cardiotoxicity in Breast Cancer Patients 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Astrocytoma 1 Adenocarcinoma Of Esophagus 1

Interventions

Temozolomide 158 Bevacizumab 68 Radiotherapy 67 Magnetic Resonance Spectroscopy 67 Irinotecan 31 Surgical Procedures, Operative 27 Radiation 24 Carboplatin 23 Specimen Handling 20 Carmustine 20 Nivolumab 19 Blood Specimen Collection 19 Aminolevulinic Acid 18 Biopsy 17 Lomustine 15 pembrolizumab 13 Radiotherapy, Intensity-Modulated 13 trametinib 12 X-Rays 12 Radiosurgery 12 Erlotinib Hydrochloride 12 Cyclophosphamide 12 fluorodopa F 18 11 Topotecan 11 Everolimus 11 Magnetic Resonance Imaging 10 IL13-PE38 10 dabrafenib 9 Etoposide 9 Drug Therapy 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07532031 2026-04-15

APT-HGG

IRCCS Ospedale San Raffaele

Not yet recruiting

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡